| Issue Date | Title | Author(s) |
| 2016-05-18 | Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing | Cole, AJ; Dwight, T; Gill, AJ; Dickson, KA; Zhu, Y; Clarkson, A; Gard, GB; Maidens, J; Valmadre, S; Clifton-Bligh, R; Marsh, DJ |
| 2017-08 | Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. | Najdawi, F; Crook, A; Maidens, J; McEvoy, C; Fellowes, A; Pickett, J; Ho, M; Nevell, D; McIlroy, K; Sheen, A; Sioson, L; Ahadi, M; Turchini, J; Clarkson, A; Hogg, R; Valmadre, S; Gard, G; Dooley, SJ; Scott, RJ; Fox, SB; Field, M; Gill, AJ |
| 2016-01-01 | Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma | Tayao, M; Andrici, J; Farzin, M; Clarkson, A; Sioson, L; Watson, N; Chua, TC; Sztynda, T; Samra, JS; Gill, AJ |
| 2020-05 | NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases. | Chou, A; Fraser, T; Ahadi, M; Fuchs, T; Sioson, L; Clarkson, A; Sheen, A; Singh, N; Corless, CL; Gill, AJ |
| 2019-01-01 | Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) parathyroid tumors demonstrate distinctive morphologic features | Gill, AJ; Lim, G; Cheung, VKY; Andrici, J; Perry-Keene, JL; Paik, J; Sioson, L; Clarkson, A; Sheen, A; Luxford, C; Elston, MS; Meyer-Rochow, GY; Nano, MT; Kruijff, S; Engelsman, AF; Sywak, M; Sidhu, SB; Delbridge, LW; Robinson, BG; Marsh, DJ; Toon, CW; Chou, A; Clifton-Bligh, RJ |
| 2016-12-15 | The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer | Dickson, K-A; Cole, AJ; Gill, AJ; Clarkson, A; Gard, GB; Chou, A; Kennedy, CJ; Henderson, BR; Fereday, S; Traficante, N; Alsop, K; Bowtell, DD; deFazio, A; Clifton-Bligh, R; Marsh, DJ |
